TR200200313T2 - Hızla çözünen dozaj formu ve bunun yapım prosesi. - Google Patents

Hızla çözünen dozaj formu ve bunun yapım prosesi.

Info

Publication number
TR200200313T2
TR200200313T2 TR2002/00313T TR200200313T TR200200313T2 TR 200200313 T2 TR200200313 T2 TR 200200313T2 TR 2002/00313 T TR2002/00313 T TR 2002/00313T TR 200200313 T TR200200313 T TR 200200313T TR 200200313 T2 TR200200313 T2 TR 200200313T2
Authority
TR
Turkey
Prior art keywords
dosage form
production process
rapidly dissolving
dissolving dosage
dosage forms
Prior art date
Application number
TR2002/00313T
Other languages
English (en)
Turkish (tr)
Inventor
Martani Rose
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of TR200200313T2 publication Critical patent/TR200200313T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/00313T 1999-08-17 2000-08-14 Hızla çözünen dozaj formu ve bunun yapım prosesi. TR200200313T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99810738 1999-08-17

Publications (1)

Publication Number Publication Date
TR200200313T2 true TR200200313T2 (tr) 2002-04-22

Family

ID=8242980

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00313T TR200200313T2 (tr) 1999-08-17 2000-08-14 Hızla çözünen dozaj formu ve bunun yapım prosesi.

Country Status (8)

Country Link
US (1) US7182959B2 (https=)
EP (1) EP1202716A1 (https=)
JP (1) JP2003506480A (https=)
AU (1) AU765526B2 (https=)
CA (1) CA2380449A1 (https=)
HK (1) HK1046236A1 (https=)
TR (1) TR200200313T2 (https=)
WO (1) WO2001012161A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
ATE321530T1 (de) * 2001-08-09 2006-04-15 Smithkline Beecham Plc Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1485296B1 (en) * 2002-02-13 2011-07-20 Michael K. Weibel Drug dose - form and method of manufacture
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
WO2004098571A1 (en) * 2003-04-30 2004-11-18 Zicam, Llc Cold remedy composition comprising zinc salts
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050214365A1 (en) * 2004-03-24 2005-09-29 Gulf Pharmaceutical Industries [Instant dissolving tablet composition for loratidine and desloratidine]
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
TWI356036B (en) * 2004-06-09 2012-01-11 Smithkline Beecham Corp Apparatus and method for pharmaceutical production
AR051397A1 (es) * 2004-10-21 2007-01-10 Novartis Ag Composicion farmaceutica
ATE398444T1 (de) * 2004-10-28 2008-07-15 Pantec Ag Herstellung einer rasch zerfallendenden festen darreichungsform ausgehend von einem pulver und einem gefriertrocknungsschritt
US20100055179A1 (en) * 2006-12-21 2010-03-04 Mallinckrodt Inc. Composition of and Method for Preparing Orally Disintegrating Tablets Containing a High Dose of Pharmaceutically Active Ingredients
CN101686942B (zh) * 2007-06-27 2012-09-26 韩美药品株式会社 用于快速制备用于口服的崩解剂的方法及其产品
EP2385769A4 (en) * 2008-12-15 2014-08-20 Valeant Pharmaceuticals Luxembourg S R L QUICKLY SOLUBLE VITAMIN FORMULATION AND METHOD FOR THEIR USE
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
EP2467130A2 (en) * 2009-08-17 2012-06-27 Waxtabs (Pty) Ltd Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
US20110105441A1 (en) * 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
DK3254676T3 (en) 2009-10-30 2019-03-11 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
EP2515879A4 (en) * 2009-12-22 2014-04-02 Fmc Corp Inc FINE PARTICLE CROSCARMELLOSIS AND USES THEREOF
RU2566269C2 (ru) 2010-03-29 2015-10-20 Ферринг Б.В. Быстрорастворимая фармацевтическая композиция
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US20150064263A1 (en) * 2010-05-25 2015-03-05 David Kossor Compositions and methods for reduction of mercury toxicity
CN103781467B (zh) 2011-09-16 2016-08-31 辉凌公司 一种快速溶解药物组合物
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311490A (en) * 1980-12-22 1982-01-19 General Electric Company Diamond and cubic boron nitride abrasive compacts using size selective abrasive particle layers
ATE24964T1 (de) * 1981-12-11 1987-01-15 Wyeth John & Brother Ltd Verfahren zur herstellung von festen formgegenstaenden.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
CA2076983A1 (en) * 1990-04-11 1991-10-12 Robert Wu-Wei Shen Taste masking of ibuprofen by fluid bed coating
ES2202302T3 (es) * 1991-05-28 2004-04-01 Mcneil-Ppc, Inc. Composicion masticable que libera un farmaco.
US5466464A (en) * 1991-12-24 1995-11-14 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
ATE260646T1 (de) * 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
JPH11116466A (ja) * 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 急速溶解型固形製剤およびその製造法
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations

Also Published As

Publication number Publication date
WO2001012161A1 (en) 2001-02-22
AU765526B2 (en) 2003-09-18
US20020131998A1 (en) 2002-09-19
AU7275700A (en) 2001-03-13
US7182959B2 (en) 2007-02-27
HK1046236A1 (zh) 2003-01-03
EP1202716A1 (en) 2002-05-08
CA2380449A1 (en) 2001-02-22
JP2003506480A (ja) 2003-02-18

Similar Documents

Publication Publication Date Title
TR200200313T2 (tr) Hızla çözünen dozaj formu ve bunun yapım prosesi.
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
SE0102438D0 (sv) New compounds
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
CY2016024I2 (el) ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
TR199802139T2 (xx) Sisaprid'in an�nda tahliye sa�layan, PH'dan ba��ms�z kat� dozaj �ekli.
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE60022188D1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
BR0316493A (pt) ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
FR2804024B1 (fr) Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
AR034435A1 (es) Agentes terapeuticos.
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
ATE344265T1 (de) Derivate von benzothiazin und benzothiadiazin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen diese enthaltend
ATE250578T1 (de) Indenoindolon-derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen
FR2816841B1 (fr) Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
ATE321530T1 (de) Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
HUP0002147A3 (en) Hydroxybenzoic acid derivatives, process for producing them and pharmaceutical compositions having antiplasmid activity comprising the said compounds
CR6300A (es) Nueva formulacion oral